Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer

Jose A. Karam, Robert S. Svatek, Pierre I. Karakiewicz, Andrea Gallina, Claus Roehrborn, Kevin M. Slawin, Shahrokh F. Shariat

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Purpose: Current predictive tools and imaging modalities are not accurate enough to preoperatively diagnose lymph node metastases in patients with prostate cancer. The aim of the study was to evaluate whether preoperative plasma endoglin improves the prediction of lymph node metastases in patients with clinically localized prostate cancer. Experimental Design: Endoglin levels were measured using a commercially available ELISA assay in banked plasma from 425 patients treated with radical prostatectomy and bilateral lymphadenectomy for clinically localized prostatic adenocarcinoma at two university hospitals between July 1994 and November 1997. Logistic regression analyses were undertaken to evaluate whether endoglin improves the accuracy of a standard preoperative model for prediction of lymph node metastasis and to build a predictive nomogram. Results: Preoperative plasma endoglin levels were higher in patients with higher preoperative total serum prostate-specific antigen (PSA; Spearman correlation coefficient 0.296, P < 0.001), positive surgical margins (P = 0.03), higher pathologic Gleason sum (P = 0.04), and lymph node metastasis (P < 0.001). In a preoperative multivariable logistic regression analysis that included PSA and clinical stage, only preoperative endoglin (odds ratio, 1.17; 95% confidence interval, 1.09-1.26; P < 0.001) and biopsy Gleason sum (odds ratio, 18.57; 95% confidence interval, 1.08-318.36; P = 0.04) were associated with metastasis to lymph nodes. The addition of endoglin to a standard preoperative model (including PSA, clinical stage, and biopsy Gleason sum) significantly improved its accuracy for prediction of lymph node metastasis from 89.4% to 97.8% (P < 0.001). Conclusions: Preoperative plasma endoglin improves the accuracy for prediction of pelvic lymph node metastasis in patients treated with radical prostatectomy for clinically localized prostate cancer by a statistically and clinically significant margin.

Original languageEnglish (US)
Pages (from-to)1418-1422
Number of pages5
JournalClinical Cancer Research
Volume14
Issue number5
DOIs
StatePublished - Mar 1 2008

Fingerprint

Prostatic Neoplasms
Lymph Nodes
Neoplasm Metastasis
Prostatectomy
Logistic Models
Odds Ratio
Regression Analysis
Confidence Intervals
Biopsy
Nomograms
Prostate-Specific Antigen
Endoglin
Lymph Node Excision
Adenocarcinoma
Research Design
Enzyme-Linked Immunosorbent Assay
Serum

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer. / Karam, Jose A.; Svatek, Robert S.; Karakiewicz, Pierre I.; Gallina, Andrea; Roehrborn, Claus; Slawin, Kevin M.; Shariat, Shahrokh F.

In: Clinical Cancer Research, Vol. 14, No. 5, 01.03.2008, p. 1418-1422.

Research output: Contribution to journalArticle

Karam, Jose A. ; Svatek, Robert S. ; Karakiewicz, Pierre I. ; Gallina, Andrea ; Roehrborn, Claus ; Slawin, Kevin M. ; Shariat, Shahrokh F. / Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer. In: Clinical Cancer Research. 2008 ; Vol. 14, No. 5. pp. 1418-1422.
@article{94a13bfc456f41e8a95c73a1180db70c,
title = "Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer",
abstract = "Purpose: Current predictive tools and imaging modalities are not accurate enough to preoperatively diagnose lymph node metastases in patients with prostate cancer. The aim of the study was to evaluate whether preoperative plasma endoglin improves the prediction of lymph node metastases in patients with clinically localized prostate cancer. Experimental Design: Endoglin levels were measured using a commercially available ELISA assay in banked plasma from 425 patients treated with radical prostatectomy and bilateral lymphadenectomy for clinically localized prostatic adenocarcinoma at two university hospitals between July 1994 and November 1997. Logistic regression analyses were undertaken to evaluate whether endoglin improves the accuracy of a standard preoperative model for prediction of lymph node metastasis and to build a predictive nomogram. Results: Preoperative plasma endoglin levels were higher in patients with higher preoperative total serum prostate-specific antigen (PSA; Spearman correlation coefficient 0.296, P < 0.001), positive surgical margins (P = 0.03), higher pathologic Gleason sum (P = 0.04), and lymph node metastasis (P < 0.001). In a preoperative multivariable logistic regression analysis that included PSA and clinical stage, only preoperative endoglin (odds ratio, 1.17; 95{\%} confidence interval, 1.09-1.26; P < 0.001) and biopsy Gleason sum (odds ratio, 18.57; 95{\%} confidence interval, 1.08-318.36; P = 0.04) were associated with metastasis to lymph nodes. The addition of endoglin to a standard preoperative model (including PSA, clinical stage, and biopsy Gleason sum) significantly improved its accuracy for prediction of lymph node metastasis from 89.4{\%} to 97.8{\%} (P < 0.001). Conclusions: Preoperative plasma endoglin improves the accuracy for prediction of pelvic lymph node metastasis in patients treated with radical prostatectomy for clinically localized prostate cancer by a statistically and clinically significant margin.",
author = "Karam, {Jose A.} and Svatek, {Robert S.} and Karakiewicz, {Pierre I.} and Andrea Gallina and Claus Roehrborn and Slawin, {Kevin M.} and Shariat, {Shahrokh F.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1158/1078-0432.CCR-07-0901",
language = "English (US)",
volume = "14",
pages = "1418--1422",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer

AU - Karam, Jose A.

AU - Svatek, Robert S.

AU - Karakiewicz, Pierre I.

AU - Gallina, Andrea

AU - Roehrborn, Claus

AU - Slawin, Kevin M.

AU - Shariat, Shahrokh F.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Purpose: Current predictive tools and imaging modalities are not accurate enough to preoperatively diagnose lymph node metastases in patients with prostate cancer. The aim of the study was to evaluate whether preoperative plasma endoglin improves the prediction of lymph node metastases in patients with clinically localized prostate cancer. Experimental Design: Endoglin levels were measured using a commercially available ELISA assay in banked plasma from 425 patients treated with radical prostatectomy and bilateral lymphadenectomy for clinically localized prostatic adenocarcinoma at two university hospitals between July 1994 and November 1997. Logistic regression analyses were undertaken to evaluate whether endoglin improves the accuracy of a standard preoperative model for prediction of lymph node metastasis and to build a predictive nomogram. Results: Preoperative plasma endoglin levels were higher in patients with higher preoperative total serum prostate-specific antigen (PSA; Spearman correlation coefficient 0.296, P < 0.001), positive surgical margins (P = 0.03), higher pathologic Gleason sum (P = 0.04), and lymph node metastasis (P < 0.001). In a preoperative multivariable logistic regression analysis that included PSA and clinical stage, only preoperative endoglin (odds ratio, 1.17; 95% confidence interval, 1.09-1.26; P < 0.001) and biopsy Gleason sum (odds ratio, 18.57; 95% confidence interval, 1.08-318.36; P = 0.04) were associated with metastasis to lymph nodes. The addition of endoglin to a standard preoperative model (including PSA, clinical stage, and biopsy Gleason sum) significantly improved its accuracy for prediction of lymph node metastasis from 89.4% to 97.8% (P < 0.001). Conclusions: Preoperative plasma endoglin improves the accuracy for prediction of pelvic lymph node metastasis in patients treated with radical prostatectomy for clinically localized prostate cancer by a statistically and clinically significant margin.

AB - Purpose: Current predictive tools and imaging modalities are not accurate enough to preoperatively diagnose lymph node metastases in patients with prostate cancer. The aim of the study was to evaluate whether preoperative plasma endoglin improves the prediction of lymph node metastases in patients with clinically localized prostate cancer. Experimental Design: Endoglin levels were measured using a commercially available ELISA assay in banked plasma from 425 patients treated with radical prostatectomy and bilateral lymphadenectomy for clinically localized prostatic adenocarcinoma at two university hospitals between July 1994 and November 1997. Logistic regression analyses were undertaken to evaluate whether endoglin improves the accuracy of a standard preoperative model for prediction of lymph node metastasis and to build a predictive nomogram. Results: Preoperative plasma endoglin levels were higher in patients with higher preoperative total serum prostate-specific antigen (PSA; Spearman correlation coefficient 0.296, P < 0.001), positive surgical margins (P = 0.03), higher pathologic Gleason sum (P = 0.04), and lymph node metastasis (P < 0.001). In a preoperative multivariable logistic regression analysis that included PSA and clinical stage, only preoperative endoglin (odds ratio, 1.17; 95% confidence interval, 1.09-1.26; P < 0.001) and biopsy Gleason sum (odds ratio, 18.57; 95% confidence interval, 1.08-318.36; P = 0.04) were associated with metastasis to lymph nodes. The addition of endoglin to a standard preoperative model (including PSA, clinical stage, and biopsy Gleason sum) significantly improved its accuracy for prediction of lymph node metastasis from 89.4% to 97.8% (P < 0.001). Conclusions: Preoperative plasma endoglin improves the accuracy for prediction of pelvic lymph node metastasis in patients treated with radical prostatectomy for clinically localized prostate cancer by a statistically and clinically significant margin.

UR - http://www.scopus.com/inward/record.url?scp=40949088879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949088879&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-07-0901

DO - 10.1158/1078-0432.CCR-07-0901

M3 - Article

C2 - 18316564

AN - SCOPUS:40949088879

VL - 14

SP - 1418

EP - 1422

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 5

ER -